A145 (Digoxin 125 mcg (0.125 mg))
Pill with imprint A145 is , and has been identified as Digoxin 125 mcg (0.125 mg). It is supplied by Qualitest Pharmaceuticals Inc..
Digoxin is used in the treatment of atrial fibrillation; heart failure and belongs to the drug classes group V antiarrhythmics, inotropic agents. Risk cannot be ruled out during pregnancy. Digoxin 125 mcg (0.125 mg) is not a controlled substance under the Controlled Substances Act (CSA).
Images for A145
Digoxin
- Imprint:
- A145
- Strength:
- 125 mcg (0.125 mg)
- Availability:
- Prescription only
- Drug Class:
- Group V antiarrhythmics
Inotropic agents - Pregnancy Category:
- C - Risk cannot be ruled out
- CSA Schedule:
- Not a controlled drug
- Labeler / Supplier:
- Qualitest Pharmaceuticals Inc.
- National Drug Code (NDC):
- 00603-3314
More about digoxin
- Digoxin Side Effects
- During Pregnancy or Breastfeeding
- Dosage Information
- Patient Tips
- Drug Images
- Drug Interactions
- Compare Alternatives
- Support Group
- Pricing & Coupons
- En Español
- 9 Reviews
- Drug class: group V antiarrhythmics
Consumer resources
- Digoxin
- Digoxin Injection
- Digoxin Oral Solution
- Digoxin Tablets
- Digoxin (Advanced Reading)
- Digoxin Intravenous (Advanced Reading)
Other brands: Lanoxin, Digox, Digitek, Lanoxicaps
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
